Compile Data Set for Download or QSAR

Found 305 hits with Last Name = 'harvey' and Initial = 'aj'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Chymotrypsinogen A (Bos taurus (bovine))	BDBM50104175 ((S)-2-Oxo-4-phenyl-3-(4-phenylazo-benzoylamino)-bu...) Show SMILES COC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(cc1)N=Nc1ccccc1 |w:24.26| Show InChI InChI=1S/C24H21N3O4/c1-31-24(30)22(28)21(16-17-8-4-2-5-9-17)25-23(29)18-12-14-20(15-13-18)27-26-19-10-6-3-7-11-19/h2-15,21H,16H2,1H3,(H,25,29)/t21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	110	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
University of Canterbury Curated by ChEMBL					Assay Description Difference between inhibition of alpha-chymotrypsin by the UV light and inhibition of alpha-chymotrypsin by the ambient light				Bioorg Med Chem Lett 11: 2441-4 (2001) BindingDB Entry DOI: 10.7270/Q2GB23BW
					More data for this Ligand-Target Pair
Chymotrypsinogen A (Bos taurus (bovine))	BDBM50104175 ((S)-2-Oxo-4-phenyl-3-(4-phenylazo-benzoylamino)-bu...) Show SMILES COC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(cc1)N=Nc1ccccc1 |w:24.26| Show InChI InChI=1S/C24H21N3O4/c1-31-24(30)22(28)21(16-17-8-4-2-5-9-17)25-23(29)18-12-14-20(15-13-18)27-26-19-10-6-3-7-11-19/h2-15,21H,16H2,1H3,(H,25,29)/t21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	130	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
University of Canterbury Curated by ChEMBL					Assay Description Inhibition constant for inhibition of alpha-chymotrypsin by the UV light				Bioorg Med Chem Lett 11: 2441-4 (2001) BindingDB Entry DOI: 10.7270/Q2GB23BW
					More data for this Ligand-Target Pair
Chymotrypsinogen A (Bos taurus (bovine))	BDBM50104175 ((S)-2-Oxo-4-phenyl-3-(4-phenylazo-benzoylamino)-bu...) Show SMILES COC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(cc1)N=Nc1ccccc1 |w:24.26| Show InChI InChI=1S/C24H21N3O4/c1-31-24(30)22(28)21(16-17-8-4-2-5-9-17)25-23(29)18-12-14-20(15-13-18)27-26-19-10-6-3-7-11-19/h2-15,21H,16H2,1H3,(H,25,29)/t21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	240	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
University of Canterbury Curated by ChEMBL					Assay Description Inhibition constant for inhibition of alpha-chymotrypsin by the UV light				Bioorg Med Chem Lett 11: 2441-4 (2001) BindingDB Entry DOI: 10.7270/Q2GB23BW
					More data for this Ligand-Target Pair
Chymotrypsinogen A (Bos taurus (bovine))	BDBM50104174 ((S)-2-Oxo-4-phenyl-3-(4-phenylazo-benzyloxycarbony...) Show SMILES COC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccc(cc1)N=Nc1ccccc1 |w:26.28| Show InChI InChI=1S/C25H23N3O5/c1-32-24(30)23(29)22(16-18-8-4-2-5-9-18)26-25(31)33-17-19-12-14-21(15-13-19)28-27-20-10-6-3-7-11-20/h2-15,22H,16-17H2,1H3,(H,26,31)/t22-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	290	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
University of Canterbury Curated by ChEMBL					Assay Description Inhibition constant for inhibition of alpha-chymotrypsin by the ambient light				Bioorg Med Chem Lett 11: 2441-4 (2001) BindingDB Entry DOI: 10.7270/Q2GB23BW
					More data for this Ligand-Target Pair
Chymotrypsinogen A (Bos taurus (bovine))	BDBM50104174 ((S)-2-Oxo-4-phenyl-3-(4-phenylazo-benzyloxycarbony...) Show SMILES COC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccc(cc1)N=Nc1ccccc1 |w:26.28| Show InChI InChI=1S/C25H23N3O5/c1-32-24(30)23(29)22(16-18-8-4-2-5-9-18)26-25(31)33-17-19-12-14-21(15-13-19)28-27-20-10-6-3-7-11-20/h2-15,22H,16-17H2,1H3,(H,26,31)/t22-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	480	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
University of Canterbury Curated by ChEMBL					Assay Description Difference between inhibition of alpha-chymotrypsin by the UV light and inhibition of alpha-chymotrypsin by the ambient light				Bioorg Med Chem Lett 11: 2441-4 (2001) BindingDB Entry DOI: 10.7270/Q2GB23BW
					More data for this Ligand-Target Pair
Chymotrypsinogen A (Bos taurus (bovine))	BDBM50104174 ((S)-2-Oxo-4-phenyl-3-(4-phenylazo-benzyloxycarbony...) Show SMILES COC(=O)C(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccc(cc1)N=Nc1ccccc1 |w:26.28| Show InChI InChI=1S/C25H23N3O5/c1-32-24(30)23(29)22(16-18-8-4-2-5-9-18)26-25(31)33-17-19-12-14-21(15-13-19)28-27-20-10-6-3-7-11-20/h2-15,22H,16-17H2,1H3,(H,26,31)/t22-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	770	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
University of Canterbury Curated by ChEMBL					Assay Description Inhibition constant for inhibition of alpha-chymotrypsin by the ambient light				Bioorg Med Chem Lett 11: 2441-4 (2001) BindingDB Entry DOI: 10.7270/Q2GB23BW
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202409 (US9238644, 16) Show SMILES CN1CCC(CC1)c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cn1 Show InChI InChI=1S/C27H31ClN6O/c1-34-14-10-19(11-15-34)23-9-7-20(16-30-23)32-26-31-17-22(28)24(33-26)8-6-18-4-2-3-5-21(18)27(12-13-27)25(29)35/h2-5,7,9,16-17,19H,6,8,10-15H2,1H3,(H2,29,35)(H,31,32,33)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202417 (US9238644, 24) Show SMILES CC(NC(=O)OC(C)(C)C)c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cc1 Show InChI InChI=1S/C29H34ClN5O3/c1-18(33-27(37)38-28(2,3)4)19-9-12-21(13-10-19)34-26-32-17-23(30)24(35-26)14-11-20-7-5-6-8-22(20)29(15-16-29)25(31)36/h5-10,12-13,17-18H,11,14-16H2,1-4H3,(H2,31,36)(H,33,37)(H,32,34,35)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202440 (US9238644, 45) Show SMILES Cn1cc(Nc2ncc(Cl)c(CCc3ccccc3C(C)(C)C(N)=O)n2)cn1 Show InChI InChI=1S/C20H23ClN6O/c1-20(2,18(22)28)15-7-5-4-6-13(15)8-9-17-16(21)11-23-19(26-17)25-14-10-24-27(3)12-14/h4-7,10-12H,8-9H2,1-3H3,(H2,22,28)(H,23,25,26)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202476 (US9238644, 77) Show SMILES COCCn1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cn1 Show InChI InChI=1S/C22H25ClN6O2/c1-31-11-10-29-14-16(12-26-29)27-21-25-13-18(23)19(28-21)7-6-15-4-2-3-5-17(15)22(8-9-22)20(24)30/h2-5,12-14H,6-11H2,1H3,(H2,24,30)(H,25,27,28)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202463 (US9238644, 65) Show SMILES Cn1cc(Nc2ncc(c(CCc3ccccc3C3(CC3)C(N)=O)n2)C(F)(F)F)cn1 Show InChI InChI=1S/C21H21F3N6O/c1-30-12-14(10-27-30)28-19-26-11-16(21(22,23)24)17(29-19)7-6-13-4-2-3-5-15(13)20(8-9-20)18(25)31/h2-5,10-12H,6-9H2,1H3,(H2,25,31)(H,26,28,29)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202412 (US9238644, 19) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2cn[nH]c2)ncc1Cl Show InChI InChI=1S/C19H19ClN6O/c20-15-11-22-18(25-13-9-23-24-10-13)26-16(15)6-5-12-3-1-2-4-14(12)19(7-8-19)17(21)27/h1-4,9-11H,5-8H2,(H2,21,27)(H,23,24)(H,22,25,26)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202411 (US9238644, 18) Show SMILES CN1CCC(CC1)n1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cn1 Show InChI InChI=1S/C25H30ClN7O/c1-32-12-8-19(9-13-32)33-16-18(14-29-33)30-24-28-15-21(26)22(31-24)7-6-17-4-2-3-5-20(17)25(10-11-25)23(27)34/h2-5,14-16,19H,6-13H2,1H3,(H2,27,34)(H,28,30,31)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202406 (US9238644, 13) Show SMILES Cn1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cn1 Show InChI InChI=1S/C20H21ClN6O/c1-27-12-14(10-24-27)25-19-23-11-16(21)17(26-19)7-6-13-4-2-3-5-15(13)20(8-9-20)18(22)28/h2-5,10-12H,6-9H2,1H3,(H2,22,28)(H,23,25,26)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202409 (US9238644, 16) Show SMILES CN1CCC(CC1)c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cn1 Show InChI InChI=1S/C27H31ClN6O/c1-34-14-10-19(11-15-34)23-9-7-20(16-30-23)32-26-31-17-22(28)24(33-26)8-6-18-4-2-3-5-21(18)27(12-13-27)25(29)35/h2-5,7,9,16-17,19H,6,8,10-15H2,1H3,(H2,29,35)(H,31,32,33)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.2	37
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202475 (US9238644, 76) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2cnn(CCO)c2)ncc1Cl Show InChI InChI=1S/C21H23ClN6O2/c22-17-12-24-20(26-15-11-25-28(13-15)9-10-29)27-18(17)6-5-14-3-1-2-4-16(14)21(7-8-21)19(23)30/h1-4,11-13,29H,5-10H2,(H2,23,30)(H,24,26,27)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202424 (US9238644, 30) Show SMILES CC(C)n1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cn1 Show InChI InChI=1S/C22H25ClN6O/c1-14(2)29-13-16(11-26-29)27-21-25-12-18(23)19(28-21)8-7-15-5-3-4-6-17(15)22(9-10-22)20(24)30/h3-6,11-14H,7-10H2,1-2H3,(H2,24,30)(H,25,27,28)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202411 (US9238644, 18) Show SMILES CN1CCC(CC1)n1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cn1 Show InChI InChI=1S/C25H30ClN7O/c1-32-12-8-19(9-13-32)33-16-18(14-29-33)30-24-28-15-21(26)22(31-24)7-6-17-4-2-3-5-20(17)25(10-11-25)23(27)34/h2-5,14-16,19H,6-13H2,1H3,(H2,27,34)(H,28,30,31)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.2	37
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202442 (US9238644, 47) Show SMILES Cc1cnc(Nc2cnn(C)c2)nc1CCc1ccccc1C1(CC1)C(N)=O Show InChI InChI=1S/C21H24N6O/c1-14-11-23-20(25-16-12-24-27(2)13-16)26-18(14)8-7-15-5-3-4-6-17(15)21(9-10-21)19(22)28/h3-6,11-13H,7-10H2,1-2H3,(H2,22,28)(H,23,25,26)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	5	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202407 (US9238644, 14) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2cnn(c2)C2CNC2)ncc1Cl Show InChI InChI=1S/C22H24ClN7O/c23-18-12-26-21(28-15-9-27-30(13-15)16-10-25-11-16)29-19(18)6-5-14-3-1-2-4-17(14)22(7-8-22)20(24)31/h1-4,9,12-13,16,25H,5-8,10-11H2,(H2,24,31)(H,26,28,29)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202464 (US9238644, 66) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2cnn(c2)C2CCNCC2)ncc1C(F)(F)F Show InChI InChI=1S/C25H28F3N7O/c26-25(27,28)20-14-31-23(33-17-13-32-35(15-17)18-7-11-30-12-8-18)34-21(20)6-5-16-3-1-2-4-19(16)24(9-10-24)22(29)36/h1-4,13-15,18,30H,5-12H2,(H2,29,36)(H,31,33,34)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202465 (US9238644, 67) Show SMILES CN1CCC(CC1)n1cc(Nc2ncc(c(CCc3ccccc3C3(CC3)C(N)=O)n2)C(F)(F)F)cn1 Show InChI InChI=1S/C26H30F3N7O/c1-35-12-8-19(9-13-35)36-16-18(14-32-36)33-24-31-15-21(26(27,28)29)22(34-24)7-6-17-4-2-3-5-20(17)25(10-11-25)23(30)37/h2-5,14-16,19H,6-13H2,1H3,(H2,30,37)(H,31,33,34)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202428 (US9238644, 34) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2cnn(CC(F)F)c2)ncc1Cl Show InChI InChI=1S/C21H21ClF2N6O/c22-16-10-26-20(28-14-9-27-30(11-14)12-18(23)24)29-17(16)6-5-13-3-1-2-4-15(13)21(7-8-21)19(25)31/h1-4,9-11,18H,5-8,12H2,(H2,25,31)(H,26,28,29)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202419 (US9238644, 25) Show SMILES Cc1n[nH]cc1Nc1ncc(Cl)c(CCc2ccccc2C2(CC2)C(N)=O)n1 Show InChI InChI=1S/C20H21ClN6O/c1-12-17(11-24-27-12)26-19-23-10-15(21)16(25-19)7-6-13-4-2-3-5-14(13)20(8-9-20)18(22)28/h2-5,10-11H,6-9H2,1H3,(H2,22,28)(H,24,27)(H,23,25,26)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202414 (US9238644, 21) Show SMILES CN1CCC(C1)n1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cn1 Show InChI InChI=1S/C24H28ClN7O/c1-31-11-8-18(15-31)32-14-17(12-28-32)29-23-27-13-20(25)21(30-23)7-6-16-4-2-3-5-19(16)24(9-10-24)22(26)33/h2-5,12-14,18H,6-11,15H2,1H3,(H2,26,33)(H,27,29,30)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202413 (US9238644, 20) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2cnn(c2)C2CCNC2)ncc1Cl Show InChI InChI=1S/C23H26ClN7O/c24-19-13-27-22(29-16-11-28-31(14-16)17-7-10-26-12-17)30-20(19)6-5-15-3-1-2-4-18(15)23(8-9-23)21(25)32/h1-4,11,13-14,17,26H,5-10,12H2,(H2,25,32)(H,27,29,30)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	7	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202399 (US9238644, 6) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2cccnc2)ncc1Cl Show InChI InChI=1S/C21H20ClN5O/c22-17-13-25-20(26-15-5-3-11-24-12-15)27-18(17)8-7-14-4-1-2-6-16(14)21(9-10-21)19(23)28/h1-6,11-13H,7-10H2,(H2,23,28)(H,25,26,27)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202423 (US9238644, 29) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2cnn(CC(F)(F)F)c2)ncc1Cl Show InChI InChI=1S/C21H20ClF3N6O/c22-16-10-27-19(29-14-9-28-31(11-14)12-21(23,24)25)30-17(16)6-5-13-3-1-2-4-15(13)20(7-8-20)18(26)32/h1-4,9-11H,5-8,12H2,(H2,26,32)(H,27,29,30)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202462 (US9238644, 64) Show SMILES COc1ccc(Nc2ncc(c(CCc3ccccc3C3(CC3)C(N)=O)n2)C(F)(F)F)cn1 Show InChI InChI=1S/C23H22F3N5O2/c1-33-19-9-7-15(12-28-19)30-21-29-13-17(23(24,25)26)18(31-21)8-6-14-4-2-3-5-16(14)22(10-11-22)20(27)32/h2-5,7,9,12-13H,6,8,10-11H2,1H3,(H2,27,32)(H,29,30,31)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	8	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202410 (US9238644, 17) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2cnn(c2)C2CCNCC2)ncc1Cl Show InChI InChI=1S/C24H28ClN7O/c25-20-14-28-23(30-17-13-29-32(15-17)18-7-11-27-12-8-18)31-21(20)6-5-16-3-1-2-4-19(16)24(9-10-24)22(26)33/h1-4,13-15,18,27H,5-12H2,(H2,26,33)(H,28,30,31)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202406 (US9238644, 13) Show SMILES Cn1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cn1 Show InChI InChI=1S/C20H21ClN6O/c1-27-12-14(10-24-27)25-19-23-11-16(21)17(26-19)7-6-13-4-2-3-5-15(13)20(8-9-20)18(22)28/h2-5,10-12H,6-9H2,1H3,(H2,22,28)(H,23,25,26)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	7.2	37
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202438 (US9238644, 44) Show SMILES CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(c2)C2CCN(C)CC2)ncc1Cl Show InChI InChI=1S/C24H30ClN7O/c1-16(23(26)33)20-6-4-3-5-17(20)7-8-22-21(25)14-27-24(30-22)29-18-13-28-32(15-18)19-9-11-31(2)12-10-19/h3-6,13-16,19H,7-12H2,1-2H3,(H2,26,33)(H,27,29,30)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202396 (US9238644, 3) Show SMILES CN1CCC(CC1)c1ccc(Nc2ncc(c(CCc3ccccc3C3(CC3)C(N)=O)n2)C(F)(F)F)cc1 Show InChI InChI=1S/C29H32F3N5O/c1-37-16-12-20(13-17-37)19-6-9-22(10-7-19)35-27-34-18-24(29(30,31)32)25(36-27)11-8-21-4-2-3-5-23(21)28(14-15-28)26(33)38/h2-7,9-10,18,20H,8,11-17H2,1H3,(H2,33,38)(H,34,35,36)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202429 (US9238644, 35) Show SMILES CC(C(N)=O)c1ccccc1CCc1nc(Nc2cn[nH]c2)ncc1Cl Show InChI	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	9	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202401 (US9238644, 8) Show SMILES CN1CCC(CC1)c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cc1 Show InChI InChI=1S/C28H32ClN5O/c1-34-16-12-20(13-17-34)19-6-9-22(10-7-19)32-27-31-18-24(29)25(33-27)11-8-21-4-2-3-5-23(21)28(14-15-28)26(30)35/h2-7,9-10,18,20H,8,11-17H2,1H3,(H2,30,35)(H,31,32,33)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202400 (US9238644, 7) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2ccc(cc2)C2CCNCC2)ncc1Cl Show InChI InChI=1S/C27H30ClN5O/c28-23-17-31-26(32-21-8-5-18(6-9-21)19-11-15-30-16-12-19)33-24(23)10-7-20-3-1-2-4-22(20)27(13-14-27)25(29)34/h1-6,8-9,17,19,30H,7,10-16H2,(H2,29,34)(H,31,32,33)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202395 (US9238644, 2) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2ccc(cc2)C2CCNCC2)ncc1C(F)(F)F Show InChI InChI=1S/C28H30F3N5O/c29-28(30,31)23-17-34-26(35-21-8-5-18(6-9-21)19-11-15-33-16-12-19)36-24(23)10-7-20-3-1-2-4-22(20)27(13-14-27)25(32)37/h1-6,8-9,17,19,33H,7,10-16H2,(H2,32,37)(H,34,35,36)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202470 (US9238644, 71) Show SMILES CC(NC(C)=O)c1ccc(Nc2ncc(c(CCc3ccccc3C3(CC3)C(N)=O)n2)C(F)(F)F)cc1 Show InChI InChI=1S/C27H28F3N5O2/c1-16(33-17(2)36)18-7-10-20(11-8-18)34-25-32-15-22(27(28,29)30)23(35-25)12-9-19-5-3-4-6-21(19)26(13-14-26)24(31)37/h3-8,10-11,15-16H,9,12-14H2,1-2H3,(H2,31,37)(H,33,36)(H,32,34,35)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	10	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202416 (US9238644, 23) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2ccccc2)ncc1Cl Show InChI InChI=1S/C22H21ClN4O/c23-18-14-25-21(26-16-7-2-1-3-8-16)27-19(18)11-10-15-6-4-5-9-17(15)22(12-13-22)20(24)28/h1-9,14H,10-13H2,(H2,24,28)(H,25,26,27)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202408 (US9238644, 15) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2ccc(nc2)C2CCNCC2)ncc1Cl Show InChI InChI=1S/C26H29ClN6O/c27-21-16-31-25(32-19-6-8-22(30-15-19)18-9-13-29-14-10-18)33-23(21)7-5-17-3-1-2-4-20(17)26(11-12-26)24(28)34/h1-4,6,8,15-16,18,29H,5,7,9-14H2,(H2,28,34)(H,31,32,33)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202412 (US9238644, 19) Show SMILES NC(=O)C1(CC1)c1ccccc1CCc1nc(Nc2cn[nH]c2)ncc1Cl Show InChI InChI=1S/C19H19ClN6O/c20-15-11-22-18(25-13-9-23-24-10-13)26-16(15)6-5-12-3-1-2-4-14(12)19(7-8-19)17(21)27/h1-4,9-11H,5-8H2,(H2,21,27)(H,23,24)(H,22,25,26)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	11	n/a	n/a	n/a	n/a	7.2	37
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202420 (US9238644, 26) Show SMILES Cc1nn(C)cc1Nc1ncc(Cl)c(CCc2ccccc2C2(CC2)C(N)=O)n1 Show InChI InChI=1S/C21H23ClN6O/c1-13-18(12-28(2)27-13)26-20-24-11-16(22)17(25-20)8-7-14-5-3-4-6-15(14)21(9-10-21)19(23)29/h3-6,11-12H,7-10H2,1-2H3,(H2,23,29)(H,24,25,26)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202443 (US9238644, 48) Show SMILES CN1CCC(CC1)n1cc(Nc2ncc(C)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cn1 Show InChI InChI=1S/C26H33N7O/c1-18-15-28-25(30-20-16-29-33(17-20)21-9-13-32(2)14-10-21)31-23(18)8-7-19-5-3-4-6-22(19)26(11-12-26)24(27)34/h3-6,15-17,21H,7-14H2,1-2H3,(H2,27,34)(H,28,30,31)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202437 (US9238644, 43) Show SMILES CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(c2)C2CCNCC2)ncc1Cl Show InChI InChI=1S/C23H28ClN7O/c1-15(22(25)32)19-5-3-2-4-16(19)6-7-21-20(24)13-27-23(30-21)29-17-12-28-31(14-17)18-8-10-26-11-9-18/h2-5,12-15,18,26H,6-11H2,1H3,(H2,25,32)(H,27,29,30)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	12	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202441 (US9238644, 46) Show SMILES Cc1cnc(Nc2cn[nH]c2)nc1CCc1ccccc1C1(CC1)C(N)=O Show InChI InChI=1S/C20H22N6O/c1-13-10-22-19(25-15-11-23-24-12-15)26-17(13)7-6-14-4-2-3-5-16(14)20(8-9-20)18(21)27/h2-5,10-12H,6-9H2,1H3,(H2,21,27)(H,23,24)(H,22,25,26)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	13	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202414 (US9238644, 21) Show SMILES CN1CCC(C1)n1cc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cn1 Show InChI InChI=1S/C24H28ClN7O/c1-31-11-8-18(15-31)32-14-17(12-28-32)29-23-27-13-20(25)21(30-23)7-6-16-4-2-3-5-19(16)24(9-10-24)22(26)33/h2-5,12-14,18H,6-11,15H2,1H3,(H2,26,33)(H,27,29,30)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	14	n/a	n/a	n/a	n/a	7.2	37
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description Adult human dermal lymphatic microvascular endothelial cells (HMVEC-dLyAD) (Cat# CC-2810, Lonza) were seeded into clear-bottom, TC treated 12 well pl...				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202418 (US9238644, 24A) Show SMILES CC(N)c1ccc(Nc2ncc(Cl)c(CCc3ccccc3C3(CC3)C(N)=O)n2)cc1 Show InChI InChI=1S/C24H26ClN5O/c1-15(26)16-6-9-18(10-7-16)29-23-28-14-20(25)21(30-23)11-8-17-4-2-3-5-19(17)24(12-13-24)22(27)31/h2-7,9-10,14-15H,8,11-13,26H2,1H3,(H2,27,31)(H,28,29,30)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	14	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202446 (US9238644, 51) Show SMILES CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C)c2)ncc1C Show InChI InChI=1S/C20H24N6O/c1-13-10-22-20(24-16-11-23-26(3)12-16)25-18(13)9-8-15-6-4-5-7-17(15)14(2)19(21)27/h4-7,10-12,14H,8-9H2,1-3H3,(H2,21,27)(H,22,24,25)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	15	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202451 (US9238644, 55) Show SMILES CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C)c2)ncc1C(F)(F)F Show InChI InChI=1S/C20H21F3N6O/c1-12(18(24)30)15-6-4-3-5-13(15)7-8-17-16(20(21,22)23)10-25-19(28-17)27-14-9-26-29(2)11-14/h3-6,9-12H,7-8H2,1-2H3,(H2,24,30)(H,25,27,28)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	15	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair
Vascular endothelial growth factor receptor 3 (Homo sapiens (Human))	BDBM202430 (US9238644, 36) Show SMILES CC(C(N)=O)c1ccccc1CCc1nc(Nc2cnn(C)c2)ncc1Cl Show InChI InChI=1S/C19H21ClN6O/c1-12(18(21)27)15-6-4-3-5-13(15)7-8-17-16(20)10-22-19(25-17)24-14-9-23-26(2)11-14/h3-6,9-12H,7-8H2,1-2H3,(H2,21,27)(H,22,24,25)	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	16	n/a	n/a	n/a	n/a	7.4	n/a
CANCER THERAPEUTICS CRC PTY LIMITED US Patent					Assay Description A biotin labelled peptide is used as substrate (amino acid sequence: Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2)....				US Patent US9238644 (2016) BindingDB Entry DOI: 10.7270/Q2JM28FP
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 305 total )  |  Next  |  Last  >>

Jump to: